Integrated Filing — IndAS

General information about company
Scrip Code	523704
NSE Symbol	MASTEK
MSEI Symbol	NOTLISTED
ISIN	INE759A01021
Name of company	MASTEK LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	18-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	07-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Geographical
Description of single segment
Start date and time of board meeting	18-Apr-2025   13:30:00
End date and time of board meeting	18-Apr-2025   15:50:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-01-16
Indicate Company website link for updated RPT policy of the Company	https://www.mastek.com/wp-content/uploads/2022/09/RelatedPartyTransactionsPolicy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1255400000	4862900000
	Other income	315200000	733500000
	Total income	1570600000	5596400000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	865400000	3353000000
(e)	Finance costs	2500000	39400000
(f)	Depreciation, depletion and amortisation expense	34200000	137400000
(f)	Other Expenses
1	Other expenses	132700000	532800000
2	Consultancy & Subcontracting charges	45700000	140200000
	Total other expenses	178400000	673000000
	Total expenses	1080500000	4202800000
3	Total profit before exceptional items and tax	490100000	1393600000
4	Exceptional items	0	0
5	Total profit before tax	490100000	1393600000
6	Tax expense
7	Current tax	58500000	199600000
8	Deferred tax	-3900000	-11800000
9	Total tax expenses	54600000	187800000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	435500000	1205800000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	435500000	1205800000
17	Other comprehensive income net of taxes	-43500000	-78800000
18	Total Comprehensive Income for the period	392000000	1127000000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	154700000	154700000
	Face value of equity share capital	5	5
27	Details of debt securities
22	Reserves excluding revaluation reserve		8971400000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	14.1	39.06
	Diluted earnings (loss) per share from continuing operations	13.97	38.7
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	14.1	39.06
	Diluted earnings (loss) per share from continuing and discontinued operations	13.97	38.7
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	329500000
	Capital work-in-progress	17400000
	Investment property	0
	Goodwill	241000000
	Other intangible assets	38200000
	Intangible assets under development	1700000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	7624000000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	141900000
	Total non-current financial assets	7765900000
	Deferred tax assets (net)	186400000
	Other non-current assets	162600000
	Total non-current assets	8742700000
2	Current assets
	Inventories	0
	Current financial asset
	Current investments	364200000
	Trade receivables, current	887000000
	Cash and cash equivalents	70400000
	Bank balance other than cash and cash equivalents	10500000
	Loans, current	0
	Other current financial assets	79300000
	Total current financial assets	1411400000
	Current tax assets (net)	0
	Other current assets	377800000
	Total current assets	1789200000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	10531900000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	154700000
	Other equity	8971400000
	Total equity attributable to owners of parent	9126100000
	Non controlling interest
	Total equity	9126100000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	20800000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	128100000
	Total non-current financial liabilities	148900000
	Provisions, non-current	271500000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	420400000
	Current liabilities
	Current financial liabilities
	Borrowings, current	10600000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	223300000
	Total Trade payable	223300000
	Other current financial liabilities	456800000
	Total current financial liabilities	690700000
	Other current liabilities	134400000
	Provisions, current	160300000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	985400000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	1405800000
	Total equity and liabilites	10531900000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Standalone	0	0
	Total Segment Revenue	0	0
	Less: Inter segment revenue
	Revenue from operations	0	0
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Standalone	0	0
	Total Profit before tax	0	0
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax	0	0
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Standalone	0	0
	Total Segment Asset	0	0
	Un-allocable Assets	10531900000	10531900000
	Net Segment Asset	10531900000	10531900000
4	Segment Liabilities
	Segment Liabilities
1	Standalone	0	0
	Total Segment Liabilities	0	0
	Un-allocable Liabilities	1405800000	1405800000
	Net Segment Liabilities	1405800000	1405800000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Defined benefit plan actuarial (loss)/ gain	1300000	-10000000
	Total Amount of items that will not be reclassified to profit and loss	1300000	-10000000
2	Income tax relating to items that will not be reclassified to profit or loss	400000	-2500000
3	Amount of items that will be reclassified to profit and loss
1	Effective portion of (losses)/ gains on hedging instruments in cash flow hedges (net)	-59300000	-62500000
2	Effective portion of losses on hedging instruments in cash flow hedges reclassified to profit or loss (net)	-100000	-32800000
	Total Amount of items that will be reclassified to profit and loss	-59400000	-95300000
4	Income tax relating to items that will be reclassified to profit or loss	-15000000	-24000000
5	Total Other comprehensive income	-43500000	-78800000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1393600000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			39400000
	Adjustments for decrease (increase) in inventories			0
	Adjustments for decrease (increase) in trade receivables, current			-208200000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-169400000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			116800000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			137400000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			588500000
	Adjustments for interest income			28800000
	Adjustments for share-based payments			18700000
	Adjustments for fair value losses (gains)			-7400000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-66100000
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-756100000
	Net cash flows from (used in) operations			637500000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			133200000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			504300000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			12000000
	Purchase of property, plant and equipment			80000000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			588500000
	Interest received			20600000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			1900000
	Net cash flows from (used in) investing activities	543000000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			3200000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			9300000
	Repayments of borrowings			470700000
	Payments of lease liabilities			11500000
	Dividends paid			586600000
	Interest paid			40200000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-1096500000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-49200000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-49200000
	Cash and cash equivalents cash flow statement at beginning of period			119600000
	Cash and cash equivalents cash flow statement at end of period			70400000